NCT05516017 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Karan A, Alptekin HK, Çapan N, Diraçoglu D, Saral I, Aydin S, Aksoy C
The efficacy of vestibular electrical stimulation on patients with unilateral vestibular pathologies. Turk J Phys Med Rehabil. 2017 Jun 3;63(2):149-154. doi: 10.5606/tftrd.2017.267. eC
Rizzo-Sierra CV, Gonzalez-Castaño A, Leon-Sarmiento FE
Galvanic vestibular stimulation: a novel modulatory countermeasure for vestibular-associated movement disorders. Arq Neuropsiquiatr. 2014 Jan;72(1):72-7. doi: 10.1590/0004-282X20130182. Review.

The Effect of Pinhole Glasses on Vestibular Electrical Stimulation Used in the Treatment of Chronic Unilateral Vestibular Hypofunction: A Randomized Controlled Study

Details for clinical trial NCT05516017

Clinical trial NCT05516017 - References